BAIAP2L1
(BAI1-Associated Protein 2-Like-1 (BAIAP2L1))
Origine
Humain, Souris, Rat
Source
Synthetic
Application
Blocking Peptide (BP)
Attributs du produit
The peptide is used to block Anti-BAIAP2L1 Antibody reactivity.
Indications d'application
Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
Restrictions
For Research Use only
Format
Lyophilized
Stock
-20 °C
Stockage commentaire
Shipped at 4°C. Store at -20°C for one year.
Date de péremption
12 months
Antigène
BAIAP2L1
(BAI1-Associated Protein 2-Like-1 (BAIAP2L1))
Synonymes
cb1023 Peptide, baiap2l1 Peptide, zgc:85624 Peptide, RGD1308452 Peptide, BAIAP2L1 Peptide, MGC131079 Peptide, 1300006M19Rik Peptide, AI585895 Peptide, IRTKS Peptide, zgc:110192 Peptide, BAI1-associated protein 2-like 1a Peptide, BAI1-associated protein 2-like 1 Peptide, BAI1 associated protein 2 like 1 Peptide, BAI1 associated protein 2 like 1 L homeolog Peptide, BAI1-associated protein 2-like 1b Peptide, baiap2l1a Peptide, Baiap2l1 Peptide, BAIAP2L1 Peptide, baiap2l1.L Peptide, baiap2l1b Peptide
Sujet
IRTKS, Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1, BAI1-associated protein 2-like protein 1, Insulin receptor tyrosine kinase substrate